Skip to main content
Clinical Trials/PACTR201308000543272
PACTR201308000543272Completed未知

Intermittent preventive treatment versus intermittent screening and treatment of malaria in pregnancy

niversity of Calabar0 sites460 target enrollmentStarted: April 29, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
460

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 Year(s) to 49 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Pregnancy (16-24 weeks gestation) confirmed at first booking
  • Willing to have supervised delivery
  • Permanent residence within the study area

Exclusion Criteria

  • Haemoglobin < 6.0 g/dl or haematocrit of <18%
  • Presence of malaria requiring parenteral medication or parasite density ¿ 100,000/mm3 of blood.
  • Past obstetric and medical history that will adversely affect the evaluation of outcomes.
  • A prior dose of SP-IPTp
  • Sensitivity to SP, lumefantrine or an artemisinin
  • An illness requiring hospital admission.
  • Known G6PD deficiency to exclude women at risk of haemolytic anaemia.
  • Women who are known to be HIV infected before enrollment will not be recruited because, according to World Health Organization (WHO) and national recommendations, they should receive 3 (rather than 2) IPTp doses.
  • Failure to meet any of the inclusion criteria stated above.

Investigators

Sponsor
niversity of Calabar

Similar Trials